Skip to main content

Table 1 Baseline characteristics of 651 overweight or obese subjects without a history of diabetes

From: Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome

 

All

Men

Women

P

Number of cases

651

193

458

 

Age (years)

43 ± 13

46 ± 12

42 ± 13

0.03

Weight (kg)

109.3 ± 21.2

124.5 ± 22.1

102.4 ± 17.2

< 0.01

BMI (kg/m2)

38.2 ± 6.1

39.0 ± 6.4

37.9 ± 5.9

0.02

Waist circumference (cm)

116.2 ± 14.8

126.3 ± 12.6

112 ± 13

< 0.01

Systolic BP (mmHg)

129 ± 15

133 ± 14

127 ± 15

0.02

Diastolic BP (mmHg)

76 ± 11

80 ± 11

75 ± 10

0.03

Triglycerides (mg/dl)

132 (97–185)

163 (114–220)

125 (91–170)

< 0.01

Total cholesterol (mg/dl)

198 (175–227)

189 (167–219)

203 (177–230)

< 0.01

HDL cholesterol (mg/dl)

49 (40–60)

42 (35–50)

52 (44–63)

< 0.01

CT visceral fat (cm2)

183 (131–249)

249 (194–315)

157 (113–209)

< 0.01

CT subcutaneous fat (cm2)

593 ± 145

562 ± 167

605 ± 132

< 0.01

CT total fat (cm2)

789 ± 173

820 ± 189

775 ± 164

< 0.01

Fasting glucose (mg/dl)

86 (80–95)

92 (84–101)

84 (79–92)

0.01

2-h OGTT glucose (mg/dl)

140 (118–167)

147 (125–185)

138 (117–161)

< 0.01

HbA1c (%)

5.5 (5.3–5.8)

5.6 (5.4–6.0)

5.4 (5.2–5.7)

0.03

HbA1c (mmol/mol)

37 (34–40)

38 (36–41)

36 (33–37)

0.03

FINDRISC score

12 ± 4

13 ± 4

12 ± 4

0.54

HOMA-S

3.3 (2.1–5.4)

4.5 (2.9–7.0)

3.0 (1.8–4.6)

< 0.01

HOMA-B (%)

243 (153–375)

241 (153–361)

247 (157–380)

0.65

Microalbuminuria (μg/min)

8.0 (5.9–13.0)

9.0 (7.0–16.0)

8.0 (5.0–12.0)

0.01

  1. Data are expressed as mean ± standard deviation or median (range)
  2. BMI body mass index, BP blood pressure, HDL high density lipoprotein, OGTT oral glucose tolerance test, HOMA-S homeostasis model assessment of insulin resistance, HOMA-B homeostasis model assessment of beta-cell function